Latest Announcements

Alembic Pharmaceuticals Ltd has announced its unaudited financial results for the quarter ended 30th June, 2026, with a revenue from operations of Rs. 2,149.77 crores and a profit for the period of Rs. 173.07 crores.

Alembic Pharmaceuticals Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with a net profit of Rs. 173.07 crore and revenue from operations of Rs. 2,149.71 crore.

Summit Securities Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, along with the limited review reports of its statutory auditors.

Raymond Realty Limited has informed the Exchange about a conference call to discuss its financial performance for the First Quarter ended June 30, 2026.

Jeena Sikho Lifecare Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 07/08/2026 to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 30th June 2026.

Morepen Laboratories Ltd reported its highest-ever quarterly revenue and earnings in Q1 FY27, with EBITDA growing by 207% and PAT by 394%. The company's CDMO mandate entered full scale commercialization phase, with Rs. 58 Cr worth of commercial CDMO dispatches already completed during the quarter.

Dr. Agarwal's Health Care Limited has announced its unaudited consolidated financial results for the quarter ended June 30, 2026, with revenue from operations growing by 26.0% YoY to ₹614 Crores, and PAT growing by 44.6% YoY to ₹55 Crores.

Raymond Realty Ltd has announced a conference call to discuss its financial performance for the first quarter ended June 30, 2026.

Zim Laboratories Limited has informed the Exchange about the schedule of a Q1FY27 Earnings Conference Call to be held on Friday, 07th August, 2026 at 12:00 p.m. IST. The call will be hosted by Go India Advisors and will feature company participants Mr. Zulfiquar Kamal, Mr. Shyam Mohan Patro, and Mr. Zain Daud.

Indian Metals & Ferro Alloys Ltd (IMFA) has reported record revenue and robust financial performance in Q1 FY27, driven by higher volumes and firm prices. The company's Greenfield Expansion Project at Kalinganagar is on track, and all four furnaces at KNR 2 are operational. IMFA has also signed a long-term offtake arrangement for additional 65 MWp hybrid renewable energy and is nearing completion of its ethanol project.

Repro India Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with the Board of Directors considering and approving the results at its meeting held on August 4, 2026. The results include standalone and consolidated financials, along with a limited review report from the statutory auditors.

Aviva Industries Ltd has scheduled a Board Meeting on August 11, 2026, to consider and approve unaudited financial results for the period ended June 30, 2026.

Meenakshi India Ltd has scheduled an earnings conference call on August 7, 2026, to discuss its Q1 FY27 results.

Capillary Technologies India Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, and received a Limited Review Report from its independent auditor, Walker Chandiok & Co LLP.

Indian Metals & Ferro Alloys Ltd (IMFA) reported record revenue and robust financial performance in Q1 FY27, driven by higher ferro chrome output and firm prices. The company's Greenfield Expansion Project at Kalinganagar is on track, with the first furnace expected to be commissioned in August 2026 and the second furnace in September 2026. IMFA has also signed a long-term offtake arrangement with Enfinity Global for an additional 65 MWp hybrid renewable energy, expected to be available by June 2027.

Dr. Agarwal's Health Care Limited announced its unaudited consolidated financial results for the quarter ended June 30, 2026, with revenue from operations growing by 26.0% YoY to ₹614 Crores, total income growing by 23.9% YoY to ₹620 Crores, IND-AS EBITDA growing by 25.2% YoY to ₹177 Crores, and PAT growing by 44.6% YoY to ₹55 Crores.

Morepen Laboratories Ltd has released its Q1 FY 27 Investor Presentation, highlighting a 34% YoY increase in revenue, 207% YoY increase in EBITDA, and 394% YoY increase in PAT. The company attributes this performance to operational execution and commercial validation of its Morepen 2.0 strategy.

Dr. Agarwal's Health Care Ltd has announced its unaudited consolidated financial results for Q1 FY2027, with revenue from operations growing by 26.0% YoY to ₹614 Crores, and PAT growing by 44.6% YoY to ₹55 Crores. The company has also announced the appointment of new auditors, internal auditors, and cost auditors, and the incorporation of a wholly owned subsidiary in Nigeria.

Greaves Cotton Ltd has announced its standalone and consolidated unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹1129.39 crore and other income at ₹11.18 crore.

Indian Metals & Ferro Alloys Ltd (IMFA) has announced its Q1 FY2027 earnings, reporting a record revenue of ₹960.45 crore, up 50% from ₹641.54 crore in Q1 FY26, driven by higher ferro chrome output and firm prices. The company's EBITDA and PAT also saw significant increases, to ₹281.27 crore and ₹191.49 crore, respectively. IMFA's Greenfield Expansion Project at Kalinganagar (KNR 1) is on track, with the first furnace expected to be commissioned in August 2026 and the second furnace in September 2026. The company has also signed a long-term offtake arrangement with Enfinity Global for an additional 65 MWp hybrid renewable energy, which will contribute to its green footprint.